New Revolutionary Treatment for Live Cancers

New Revolutionary Treatment for Live Cancers

SUNNYVALE, Calif.–(BUSINESS WIRE)–Embolx, Inc., a medical device company, announced today that the Company has been awarded a Small Business Innovation Research (SBIR) grant valued at $2 million from the National Cancer Institute (NCI) of the National...